Sushant Sahastrabuddhe, MBBS, MPH, MBA, is the Director of the Enteric Fever Program at IVI. Dr. Sahastrabuddhe has been with IVI for the past 8 years, and is currently leading the typhoid conjugate vaccine development program involving multiple manufacturers. He is a medical graduate from India with a Master’s degree in Public Health from Johns Hopkins Bloomberg School of Public Health in Baltimore, Maryland, U.S.A. Before joining IVI, he was working with the National AIDS Research Institute (NARI) under the umbrella of the Indian Council of Medical Research (ICMR) for 4 years. He has been involved in many phase I/II trials, including those for HIV vaccines. During his previous assignment at NARI, he was also involved in the monitoring of the HIV Sentinel Surveillance system under the National AIDS Control Organization (NACO) for the western states of India. Owing to his extensive experience in conducting and managing clinical trials and major public health initiatives, he has authored more than 10 publications and 2 book chapters.